How can we better align public investment with public benefit
The APIC is available 24/7, 365 days a year to provide poison advice for all ages
The 21st century has seen significant progress in GLP-1R agonist research, with liraglutide (exenatide) becoming the first GLP-1R agonist to be approved by the US Food and Drug Administration (FDA) for the treatment of T2DM in 2005 (Jensterle et al., 2022)
Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS)
Guidance to Paramedics and EMS Personnel When EMS personnel encounter a patient who is taking a semaglutide they should start with performing a thorough patient assessment with a heightened focus on fluid status, blood pressure, mental status and blood glucose level
**Before all virtual visits to discuss possible weight loss prescriptions, please contact your insurance company to find out which medications (if any) may be covered